Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
2 regions · 11 outlets · 13 reports — every source grouped by where each outlet is based. Region reflects only headquarters, not the subject of the report.
US
8 articles · 6 outlets
Moderna shares surge after it says experimental mRNA cancer treatment passed key test
This mRNA vaccine could potentially prevent the return of the deadliest form of skin cancer
New mRNA vaccine could reduce the recurrence and spread of skin cancer
How Moderna's melanoma mRNA vaccine could fight deadliest skin cancer
Moderna stock surges as melanoma vaccine trial shows "landmark moment
Experimental melanoma vaccine shows promising results
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
Moderna and Merck shares soar on mRNA cancer vaccine
Other
5 articles · 5 outlets
Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
STAT+: One of the most consequential years for cancer treatment, ever
Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?
Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
MRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say